Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 22 , ISSUE 11 ( 2018 ) > List of Articles


Severe sepsis due to chryseobacterium indologenes, a possible emergent multidrug-resistant organism in intensive care unit-acquired infections

Sonika Agarwal, Barnali Kakati

Keywords : Chryseobacterium indologenes, hospital acquired infection, multidrug resistance

Citation Information : Agarwal S, Kakati B. Severe sepsis due to chryseobacterium indologenes, a possible emergent multidrug-resistant organism in intensive care unit-acquired infections. Indian J Crit Care Med 2018; 22 (11):817-819.

DOI: 10.4103/ijccm.IJCCM_278_18

License: CC BY-ND 3.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Opportunistic infections in the intensive care unit are quite common which can cause devastating disease in many hospitalized and immunocompromised patients. Chryseobacterium indologenes is one such microorganism which is an emerging cause of nosocomial infections. Many cases had been reported from its infections, but the treatment protocol for its management is still not established. We present two cases of C. indologenes infections which were hospital acquired. The pandrug-resistant nature of the bacteria and the associated mortality were uncommon with these two cases.

PDF Share
  1. Lin YT, Jeng YY, Lin ML, Yu KW, Wang FD, Liu CY, et al. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010;43:498-505.
  2. Calderón G, García E, Rojas P, García E, Rosso M, Losada A, et al. Chryseobacterium indologenes infection in a newborn: A case report. J Med Case Rep 2011;5:10.
  3. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001;7:391-3.
  4. Cascio A, Stassi G, Costa GB, Crisafulli G, Rulli I, Ruggeri C, et al. Chryseobacterium indologenes bacteraemia in a diabetic child. J Med Microbiol 2005;54:677-80.
  5. Green BT, Nolan PE. Cellulitis and bacteraemia due to Chryseobacterium indologenes. J Infect 2001;42:219-20.
  6. Chou DW, Wu SL, Lee CT, Tai FT, Yu WL. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit. Jpn J Infect Dis 2011;64:520-4.
  7. Chen FL, Wang GC, Teng SO, Ou TY, Yu FL, Lee WS, et al. Clinical and epidemiological features of Chryseobacterium indologenes infections: Analysis of 215 cases. J Microbiol Immunol Infect 2013;46:425-32.
  8. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT, et al. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997;16:568-74.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.